Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000012

Chief Scientific Officer sold 6,812 shares at an average $32.39 ($220,608)

  • Chief Scientific Officer acquired 6,812 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-28 Exercise or conversion : show line 1 in the form +3,973 $26.49 $105,245 236,523 D
2021-06-28 Sale : show line 2 in the form −3,973 $32.43 $128,855 232,550 D
2021-06-28 Exercise or conversion : show line 3 in the form +1,891 $26.49 $50,093 234,441 D
2021-06-28 Sale : show line 4 in the form −1,891 $32.23 $60,950 232,550 D
2021-06-28 Exercise or conversion : show line 5 in the form +948 $19.47 $18,458 233,498 D
2021-06-28 Sale : show line 6 in the form −948 $32.49 $30,804 232,550 D
Open-market sales · 6,812 sh · avg $32.39 · $220,608

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-06-28 Exercise or conversion : show line 7 in the form Incentive Stock Option (right to buy) −1,891 1,884 D
2021-06-28 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) −948 17,692 D
2021-06-28 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −3,973 172,252 D
Loading xslF345X03/edgardoc.xml…